1
Jong Y Lee, Satish K Dharmaraj: Method and apparatus for providing security for servers executing application programs received via a network. Sun Microsystems, Blakely Sokoloff Taylor & Zafman, December 26, 2000: US06167522 (51 worldwide citation)

A method and apparatus for providing security to a server running an application program received over a network is provided. The application program, along with a source identifier is received from a source computer. Access privileges to server resources are granted based on the source identifier. ...


2
Jong Y Lee: Purified human erythropoietin receptor protein fragment and antibodies derived therefrom. Hugh McTavish, May 30, 2006: US07053184 (5 worldwide citation)

A E. coli recombinant plasmid expressing a fusion protein having the human erythropoietin receptor extracellular domain is disclosed. A purified fusion protein produced from such a vector is also disclosed, the fusion protein having a cleavage site suitable for separating the erythropoietin receptor ...


3
Jong Y Lee: Expression of a cleavable fusion protein comprising a soluble human erythropoietin receptor protein fragment. Fish & Richardson P C P A, December 1, 1998: US05843726 (3 worldwide citation)

An E. coli recombinant plasmid expressing a fusion protein having the human erythropoietin receptor extracellular domain is disclosed. A purified fusion protein produced from such a vector is also disclosed, the fusion protein having a cleavage site suitable for separating the erythropoietin recepto ...


4
Jong Y Lee, Mary S Lee, John S Lee: Detection of erythropoietin and erythropoietin receptor. Jong Y Lee, Cyr & Associates P A, December 25, 2007: US07312089

The invention is based on the development of several sensitive and simple methods for detecting erythropoietin and the erythropoietin receptor and associated antibodies. The methods and reagents are useful for differential diagnosis in Epo and EpoR related clinical problems. Methods and kits for sim ...


5
Jong Y Lee, John S Lee, Mary S Lee: Compositions and methods for preventing erythropoietin-associated hypertension. Hakanson Patent Law, Sten Hakanson, January 10, 2017: US09539308

The inventors have discovered that both soluble erythropoietin-binding protein and antibodies against the erythropoietin-binding protein, when they are administered to a mammal along with erythropoietin (Epo), prevent or reduce the blood pressure increase normally caused by erythropoietin, while not ...


6
Jong Y Lee: Purified human erythropoietin receptor protein fragment and antibodies derived therefrom. Fish & Richardson PC Pa, March 14, 2002: US20020031806-A1

A E. coli recombinant plasmid expressing a fusion protein having the human erythropoietin receptor extracellular domain is disclosed. A purified fusion protein produced from such a vector is also disclosed, the fusion protein having a cleavage site suitable for separating the erythropoietin receptor ...


7
Jong Y Lee, Mary S Lee, John S Lee: Detection of erythropoietin and erythropoietin receptor. Kinney & Lange Pa, September 25, 2003: US20030180822-A1

Methods and kits for simultaneous measurement of erythropoietin and erythropoietin receptor in a biological sample are described.


8
Jong Y Lee, Mary S Lee, John S Lee: Compositions and methods for preventing erythropoietin-associated hypertension. Hugh McTavish, McTavish Patent Firm, November 17, 2005: US20050255112-A1

The inventors have discovered that both soluble erythropoietin-binding protein and antibodies against the erythropoietin-binding protein, when they are administered to a mammal along with erythropoietin (Epo), prevent or reduce the blood pressure increase normally caused by erythropoietin, while not ...


9
Jong Y Lee, Mary S Lee, John S Lee: Compositions and Methods for Preventing Erythropoietin-Associated Hypertension. Jong Y Lee, March 15, 2012: US20120064079-A1

The inventors have discovered that both soluble erythropoietin-binding protein and antibodies against the erythropoietin-binding protein, when they are administered to a mammal along with erythropoietin (Epo), prevent or reduce the blood pressure increase normally caused by erythropoietin, while not ...



Click the thumbnails below to visualize the patent trend.